Citigroup offers six predictions for specialty pharma in 2006. 1. Says Sepracor (Nasdaq: SEPR) is their top pick for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE